TGFB1 and idiopathic pulmonary fibrosis: In a bleomycin (BLM)-induced IPF model, hucMSC-EV treatment inhibited myofibroblast differentiation and collagen deposition by delivering miR-21-5p/miR-23-3p to suppress the TGF-β pathway (81).